相似文献
1
Lessons learned from next-generation sequencing in head and neck cancer.
Head Neck. 2013 Mar;35(3):454-63. doi: 10.1002/hed.23100. Epub 2012 Aug 21.
2
Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Cancer. 2018 Jan 1;124(1):84-94. doi: 10.1002/cncr.31063. Epub 2017 Oct 20.
3
Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
Oncotarget. 2016 Sep 20;7(38):61575-61586. doi: 10.18632/oncotarget.11196.
4
Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
Eur J Cancer. 2016 Apr;57:78-86. doi: 10.1016/j.ejca.2016.01.003. Epub 2016 Feb 18.
5
Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res. 2016 Jun 15;22(12):2939-49. doi: 10.1158/1078-0432.CCR-15-2314. Epub 2016 Jan 13.
6
Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.
Cancer Res Treat. 2019 Jan;51(1):300-312. doi: 10.4143/crt.2018.012. Epub 2018 May 9.
7
The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.
Oncotarget. 2014 Oct 15;5(19):8906-23. doi: 10.18632/oncotarget.2417.
8
Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary.
Int J Cancer. 2020 Jun 1;146(11):3053-3064. doi: 10.1002/ijc.32882. Epub 2020 Mar 11.
9
Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
Gynecol Oncol. 2018 Sep;150(3):552-561. doi: 10.1016/j.ygyno.2018.06.026. Epub 2018 Jul 3.
10
Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva.
Hum Pathol. 2019 Oct;92:67-80. doi: 10.1016/j.humpath.2019.08.003. Epub 2019 Aug 19.
引用本文的文献
1
In Silico Discovery of a Novel Natural Product Targeting PI3Kα for the Treatment of Head and Neck Squamous Cell Carcinoma.
Int J Mol Sci. 2025 Apr 10;26(8):3565. doi: 10.3390/ijms26083565.
2
p16 Expression in Laryngeal Squamous Cell Carcinoma: A Surrogate or Independent Prognostic Marker?
Pathogens. 2024 Jan 24;13(2):100. doi: 10.3390/pathogens13020100.
3
Updates on Larynx Cancer: Risk Factors and Oncogenesis.
Int J Mol Sci. 2023 Aug 18;24(16):12913. doi: 10.3390/ijms241612913.
4
Analysis of nsSNPs of Human KRAS Gene and Protein Modeling Using Bioinformatic Tools.
ACS Omega. 2023 Apr 3;8(14):13362-13370. doi: 10.1021/acsomega.3c00804. eCollection 2023 Apr 11.
5
T cell effects and mechanisms in immunotherapy of head and neck tumors.
Cell Commun Signal. 2023 Mar 5;21(1):49. doi: 10.1186/s12964-023-01070-y.
6
Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma.
Int J Mol Sci. 2022 Jul 17;23(14):7889. doi: 10.3390/ijms23147889.
7
Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Clin Transl Oncol. 2022 Oct;24(10):1890-1902. doi: 10.1007/s12094-022-02856-1. Epub 2022 Jun 23.
8
Genomic Alterations in Human Papillomavirus-Positive and -Negative Conjunctival Squamous Cell Carcinomas.
Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):11. doi: 10.1167/iovs.62.14.11.
9
Molecular Pathways and Druggable Targets in Head and Neck Squamous Cell Carcinoma.
Cancers (Basel). 2021 Jul 9;13(14):3453. doi: 10.3390/cancers13143453.
10
Molecular landscape of head and neck cancer and implications for therapy.
Ann Transl Med. 2021 May;9(10):915. doi: 10.21037/atm-20-6264.
本文引用的文献
1
Molecular pathogenesis of pancreatic cancer and clinical perspectives.
Oncology. 2011;81(3-4):259-72. doi: 10.1159/000334449. Epub 2011 Nov 23.
2
TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.
Clin Cancer Res. 2012 Jan 1;18(1):290-300. doi: 10.1158/1078-0432.CCR-11-2260. Epub 2011 Nov 16.
3
Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17761-6. doi: 10.1073/pnas.1114669108. Epub 2011 Oct 17.
4
Temporal dissection of tumorigenesis in primary cancers.
Cancer Discov. 2011 Jul;1(2):137-43. doi: 10.1158/2159-8290.CD-11-0028. Epub 2011 Jun 29.
5
Human papillomavirus and rising oropharyngeal cancer incidence in the United States.
J Clin Oncol. 2011 Nov 10;29(32):4294-301. doi: 10.1200/JCO.2011.36.4596. Epub 2011 Oct 3.
6
The role of HPV in head and neck cancer and review of the HPV vaccine.
Prev Med. 2011 Oct;53 Suppl 1(Suppl 1):S5-S11. doi: 10.1016/j.ypmed.2011.08.001.
7
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1.
Science. 2011 Aug 26;333(6046):1154-7. doi: 10.1126/science.1206923. Epub 2011 Jul 28.
8
The mutational landscape of head and neck squamous cell carcinoma.
Science. 2011 Aug 26;333(6046):1157-60. doi: 10.1126/science.1208130. Epub 2011 Jul 28.
9
Detection and quantification of rare mutations with massively parallel sequencing.
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9530-5. doi: 10.1073/pnas.1105422108. Epub 2011 May 17.
10
p16(INK4a)/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough?
Cancer Lett. 2011 Jul 28;306(2):134-41. doi: 10.1016/j.canlet.2011.02.039. Epub 2011 Mar 15.
Zotero 插件